Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.98B | 1.91B | 1.58B | 1.32B | 1.28B | 1.07B |
Gross Profit | 286.50M | 268.70M | 229.00M | 178.80M | 189.90M | 170.90M |
EBITDA | 308.50M | 290.90M | 261.70M | 183.60M | 205.10M | 179.00M |
Net Income | 138.90M | 139.60M | 154.40M | 90.00M | 121.70M | 106.30M |
Balance Sheet | ||||||
Total Assets | 2.02B | 2.11B | 2.07B | 1.76B | 1.49B | 1.44B |
Cash, Cash Equivalents and Short-Term Investments | 189.60M | 231.00M | 156.90M | 248.70M | 191.00M | 105.80M |
Total Debt | 389.40M | 391.80M | 368.90M | 22.10M | 26.70M | 27.90M |
Total Liabilities | 1.09B | 1.18B | 1.10B | 713.30M | 596.90M | 550.80M |
Stockholders Equity | 928.00M | 926.10M | 968.30M | 1.04B | 889.40M | 884.70M |
Cash Flow | ||||||
Free Cash Flow | 205.50M | 146.80M | 97.00M | 104.40M | 102.10M | 46.60M |
Operating Cash Flow | 289.60M | 243.10M | 206.00M | 188.70M | 181.60M | 156.00M |
Investing Cash Flow | -98.20M | -99.10M | -464.40M | -81.60M | -53.20M | -185.50M |
Financing Cash Flow | -103.50M | -63.20M | 159.70M | -47.30M | -55.60M | -48.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £2.71B | 17.97 | -23.92% | 1.11% | 10.36% | 32.77% | |
65 Neutral | $10.77B | 15.80 | 5.51% | 1.90% | 3.03% | -26.66% | |
$75.09B | 30.67 | 17.85% | 1.71% | ― | ― | ||
78 Outperform | £585.74M | 115.52 | 4.18% | 1.31% | 14.69% | ― | |
76 Outperform | £713.32M | 32.70 | 18.73% | 0.68% | 13.49% | 47.00% | |
75 Outperform | £1.51B | 38.81 | 11.62% | 1.86% | 8.00% | 674.47% | |
72 Outperform | £138.98M | 32.16 | 3.87% | 0.90% | 14.30% | -25.58% |